RA
AMRI
Royce & Associates’s Albany Molecular Research Inc AMRI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-396,275
| Closed | -$8.6M | – | 1285 |
|
2017
Q2 | $8.6M | Sell |
396,275
-1,122,001
| -74% | -$24.3M | 0.06% | 429 |
|
2017
Q1 | $21.3M | Buy |
1,518,276
+227,365
| +18% | +$3.19M | 0.14% | 201 |
|
2016
Q4 | $24.2M | Buy |
1,290,911
+36,615
| +3% | +$687K | 0.16% | 183 |
|
2016
Q3 | $20.7M | Buy |
1,254,296
+70,327
| +6% | +$1.16M | 0.14% | 204 |
|
2016
Q2 | $15.9M | Buy |
1,183,969
+104,500
| +10% | +$1.4M | 0.11% | 263 |
|
2016
Q1 | $16.5M | Buy |
1,079,469
+93,254
| +9% | +$1.43M | 0.1% | 263 |
|
2015
Q4 | $19.6M | Sell |
986,215
-105,101
| -10% | -$2.09M | 0.12% | 231 |
|
2015
Q3 | $19M | Sell |
1,091,316
-128,000
| -10% | -$2.23M | 0.1% | 251 |
|
2015
Q2 | $24.7M | Sell |
1,219,316
-71,900
| -6% | -$1.45M | 0.1% | 250 |
|
2015
Q1 | $22.7M | Buy |
1,291,216
+55,200
| +4% | +$972K | 0.09% | 296 |
|
2014
Q4 | $20.1M | Buy |
1,236,016
+93,346
| +8% | +$1.52M | 0.07% | 355 |
|
2014
Q3 | $25.2M | Sell |
1,142,670
-172,940
| -13% | -$3.82M | 0.09% | 289 |
|
2014
Q2 | $26.5M | Sell |
1,315,610
-29,000
| -2% | -$583K | 0.08% | 311 |
|
2014
Q1 | $25M | Sell |
1,344,610
-67,958
| -5% | -$1.26M | 0.07% | 317 |
|
2013
Q4 | $14.2M | Buy |
1,412,568
+417,858
| +42% | +$4.21M | 0.04% | 531 |
|
2013
Q3 | $12.8M | Sell |
994,710
-109,000
| -10% | -$1.41M | 0.04% | 544 |
|
2013
Q2 | $13.1M | Buy |
+1,103,710
| New | +$13.1M | 0.04% | 522 |
|